Dark

TNXP
Tonix Pharmaceuticals Holding Corp.
stock NASDAQ

At Close

Jun 18, 2025 3:59:48 PM EDT

34.32USD-1.718%(-0.60)480,999

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jun 18, 2025 9:25:30 AM EDT

34.79USD-0.372%(-0.13)3,309

After-hours

Jun 18, 2025 4:44:30 PM EDT

34.32USD0.000%(0.00)12,826

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

252.50M

CEO

Seth Lederman

Headquarters

New York, USA

Industry

Biotechnology

Last Split

Feb 5, 20251for100reverse

ARQL SUPN PRGO AGRX XLV

TNXP Stats

Avg. Vol. 10 Day

721,574

Avg. Vol. 30 Day

1,123,948

Employees

Market Cap

252,499,035

Shares Out.

7,357,198

On/Off Exchange

36%/64%

6 Month Beta

0.53

1 Year Beta

0.89

2 Year Beta

0.84

3 Year Beta

0.98

52 Week Low

6.76

52 Week High

137.25

SMA50

25.95

SMA200

21.26

1 Week

-0.64%

1 Month

+29.02%

3 Month

+108.38%

6 Month

-39.79%

1 Year

-74.58%

2 Year

-99.39%

5 Year

-99.99%

Profile

tonix is developing innovative pharmaceutical products to address major public health challenges. in addition to tonmya for ptsd, tonix is developing tnx-601 (tianeptine oxalate), a clinical candidate at pre-ind (investigational new drug) application stage, designed as a daytime treatment for ptsd and tnx-801, a live synthetic version of horsepox virus, at the pre-ind application stage, to be developed as a potential smallpox-preventing vaccine. further information about tonix can be found at www.tonixpharma.com.

TNXP Stock Summary

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stock price today is $34.32, and today's volume is 480,999. TNXP is down -1.718% today. The 30 day average volume is 1,123,948. TNXP market cap is 252.50M with 7,357,198 shares outstanding.